U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination
    • Showing Current items.

    RETNLB resistin like beta [ Homo sapiens (human) ]

    Gene ID: 84666, updated on 27-Aug-2024

    GeneRIFs: Gene References Into Functions

    GeneRIFPubMed TitleDate
    Resistin-like beta reduction is associated to low survival rate and is downregulated by adjuvant therapy in colorectal cancer patients.

    Resistin-like beta reduction is associated to low survival rate and is downregulated by adjuvant therapy in colorectal cancer patients.
    Di Rosa M, Di Cataldo A, Broggi G, Caltabiano R, Tibullo D, Castrogiovanni P, Imbesi R, Lanteri R, Salomone F, Raciti G, Li Volti G., Free PMC Article

    02/4/2023
    Investigating resistin like beta (RETNLB) as a tumor promoter for oral squamous cell carcinoma.

    Investigating resistin like beta (RETNLB) as a tumor promoter for oral squamous cell carcinoma.
    Jin H, Miao H, Nie YW, Lin YY., Free PMC Article

    07/17/2021
    Helicobacter pylori Infection Facilitates the Expression of Resistin-like Molecule Beta in Gastric Carcinoma and Precursor Lesions.

    Helicobacter pylori Infection Facilitates the Expression of Resistin-like Molecule Beta in Gastric Carcinoma and Precursor Lesions.
    Li HJ, Fang EH, Wang JQ, Zheng LD, Tong QS.

    10/24/2020
    Plasma RELMbeta levels in necrotizing enterocolitis group were significantly higher than control group.

    Early diagnosis of necrotizing enterocolitis by plasma RELMβ and thrombocytopenia in preterm infants: A pilot study.
    Luo J, Li HP, Xu F, Wu BQ, Lin HC.

    02/1/2020
    Investigated the function and mechanism of RELM-beta in TGF-beta1-induced endothelium-mesenchymal transition in endothelial cell lines. We found that TGF-beta1 stimulation significantly upregulated RELM-beta expression; RELM-beta knockdown could attenuate TGF-beta1-induced cell proliferation and migration of endothelial cell lines.

    TGF-β1-induced SMAD2/3/4 activation promotes RELM-β transcription to modulate the endothelium-mesenchymal transition in human endothelial cells.
    Jiang Y, Zhou X, Hu R, Dai A.

    06/15/2019
    RELMbeta-overexpression can facilitate invasion and migration of gastric carcinoma cells.

    Resistin-Like Molecule-β Promotes Invasion and Migration of Gastric Carcinoma Cells.
    Jiang R, Zhao C, Wang X, Wang S, Sun X, Tian Y, Song W., Free PMC Article

    12/17/2016
    RELMbeta levels were increased in Abdominal aortic aneurysm patients in the serum and in the aortic tissue. Increased RELMbeta levels may be involved in the pathogenesis of AAA formation and progress.

    Association of resistin-like molecule β levels and abdominal aortic aneurysm.
    Meng X, Kong J, Zhang K, Yang J, Li J, Zhang Y.

    05/14/2016
    The data demonstrated that RELM-a is a promising novel biomarker of angiogenesis in patients with gastric cancer.

    High expression of RELM-α correlates with poor prognosis and promotes angiogenesis in gastric cancer.
    Chen P, Zhao D, Wang W, Zhang Y, Yuan Y, Wang L, Wu Y.

    03/19/2016
    elevated RELM-beta expression in asthmatic airways contributes to airways remodelling at least partly by increasing fibroblast proliferation and differentiation with resulting deposition of extracellular matrix proteins.

    Resistin-like molecule-β (RELM-β) targets airways fibroblasts to effect remodelling in asthma: from mouse to man.
    Fang CL, Yin LJ, Sharma S, Kierstein S, Wu HF, Eid G, Haczku A, Corrigan CJ, Ying S., Free PMC Article

    01/16/2016
    It is concluded that proper exercise training prevents up-regulation of FIZZ1/RELMalpha induced by cigarette smoking, which may be involved in the mechanism of proper exercise training modulating airway hyperresponsiveness.

    Exercise training attenuated chronic cigarette smoking-induced up-regulation of FIZZ1/RELMα in lung of rats.
    Ma WL, Cai PC, Xiong XZ, Ye H.

    09/13/2014
    RELMbeta is abundantly expressed in foam cells within plaques and contributes to atherosclerosis development via lipid accumulation and inflammatory facilitation.

    Resistin-like molecule β is abundantly expressed in foam cells and is involved in atherosclerosis development.
    Kushiyama A, Sakoda H, Oue N, Okubo M, Nakatsu Y, Ono H, Fukushima T, Kamata H, Nishimura F, Kikuchi T, Fujishiro M, Nishiyama K, Aburatani H, Kushiyama S, Iizuka M, Taki N, Encinas J, Sentani K, Ogonuki N, Ogura A, Kawazu S, Yasui W, Higashi Y, Kurihara H, Katagiri H, Asano T.

    09/28/2013
    Epithelial cell derived Fizz1 transgene is sufficient to increase bone-marrow derived dendritic cells in the lungs.

    Resistin-like molecule α1 (Fizz1) recruits lung dendritic cells without causing pulmonary fibrosis.
    Madala SK, Edukulla R, Davis KR, Schmidt S, Davidson C, Kitzmiller JA, Hardie WD, Korfhagen TR., Free PMC Article

    08/10/2013
    RELM-beta may play an important role not only in animal models of airway remodelling, but also in human airway pathology.

    Resistin-like molecule-β is induced following bronchoconstriction of asthmatic airways.
    Grainge C, Dulay V, Ward J, Sammut D, Davies E, Green B, Lau L, Cottey L, Haitchi HM, Davies DE, Howarth PH.

    03/2/2013
    RELM-beta has the potential to contribute to airway remodelling in diseases such as asthma by acting on epithelial cells to increase proliferation, mucin and growth factor production, at least partly via ERK/MAPK-PI3K/Akt signalling pathways.

    Resistin-like molecule-β is a human airway remodelling mediator.
    Fang C, Meng Q, Wu H, Eid G, Zhang G, Zhang X, Yang S, Huang K, Lee TH, Corrigan CJ, Ying S.

    06/2/2012
    Data show that over-expression of RELMbeta abolishes the invasion, metastasis and angiogenesis of gastric cancer cells in vitro.

    Effects of resistin-like molecule β over-expression on gastric cancer cells in vitro.
    Zheng LD, Yang CL, Qi T, Qi M, Tong L, Tong QS., Free PMC Article

    04/28/2012
    High RELMbeta is associated with colorectal cancer.

    Plasma levels of resistin-like molecule beta in humans.
    Neilson AP, Djuric Z, Land S, Kato I., Free PMC Article

    01/21/2012
    FIZZ2 is highly induced in lungs of human patients with idiopathic pulmonary fibrosis.

    FIZZ2/RELM-β induction and role in pulmonary fibrosis.
    Liu T, Baek HA, Yu H, Lee HJ, Park BH, Ullenbruch M, Liu J, Nakashima T, Choi YY, Wu GD, Chung MJ, Phan SH., Free PMC Article

    09/3/2011
    Gastric cncer patients showing positive RELMbeta expression had a significantly longer overall survival than those with negative expression (P = 0.001).

    Expression of resistin-like molecule beta in gastric cancer: its relationship with clinicopathological parameters and prognosis.
    Zheng L, Weng M, He J, Yang X, Jiang G, Tong Q.

    02/8/2010
    Results suggest that RELM-beta may be involved in the development of scleroderma-associated pulmonary hypertension.

    Resistin-like molecule-beta in scleroderma-associated pulmonary hypertension.
    Angelini DJ, Su Q, Yamaji-Kegan K, Fan C, Teng X, Hassoun PM, Yang SC, Champion HC, Tuder RM, Johns RA., Free PMC Article

    01/21/2010
    Of the 80 colon cancer patients studied, 65 (81.25%) tested positive for RELM beta, mainly in the cytoplasm of colon mucosa.

    Enhanced expression of resistin-like molecule beta in human colon cancer and its clinical significance.
    Zheng LD, Tong QS, Weng MX, He J, Lv Q, Pu JR, Jiang GS, Cai JB, Liu Y, Hou XH.

    01/21/2010
    High levels of RELMbeta can be detected in the stool of mice and humans, where it exists as a homodimer under nonreducing conditions.

    Bacterial colonization leads to the colonic secretion of RELMbeta/FIZZ2, a novel goblet cell-specific protein.
    He W, Wang ML, Jiang HQ, Steppan CM, Shin ME, Thurnheer MC, Cebra JJ, Lazar MA, Wu GD.

    01/21/2010
    Supernatant from COS cells transfected with the CCRG (RETNLB) expression vector stimulated proliferation of colon cancer cells, which supports the growth factor nature of the RETNLB gene.

    Bioinformatics-based discovery of a novel factor with apparent specificity to colon cancer.
    De Young MP, Damania H, Scheurle D, Zylberberg C, Narayanan R.

    10/2/2003
    firstprevious page of 1 nextlast